Raymond James Analyst: 'Optimistic About Data' From Pfizer, Moderna
Raymond James Analyst: 'Optimistic About Data' From Pfizer, Moderna

Raymond James analyst Steven Seedhouse joins TheStreet to discuss COVID-19 vaccine candidates.